{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T23:29:34Z","timestamp":1768174174452,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,11]]},"DOI":"10.7759\/cureus.101296","type":"journal-article","created":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T20:26:45Z","timestamp":1768163205000},"source":"Crossref","is-referenced-by-count":0,"title":["Microbiome Differences in Preeclampsia Versus Lupus Nephritis"],"prefix":"10.7759","author":[{"given":"Harshita","family":"Nadella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia L","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Greenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley L","year":"2009","unstructured":"Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009, 33:130-7. 10.1053\/j.semperi.2009.02.010","journal-title":"Semin Perinatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine RJ","year":"2006","unstructured":"Levine RJ, Lam C, Qian C, et al.. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006, 355:992-1005. 10.1056\/NEJMoa055352","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana S","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019, 124:1094-112. 10.1161\/CIRCRESAHA.118.313276","journal-title":"Circ Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2010.00831.x","article-title":"Immunology of pre-eclampsia","volume":"63","author":"Redman CW","year":"2010","unstructured":"Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010, 63:534-43. 10.1111\/j.1600-0897.2010.00831.x","journal-title":"Am J Reprod Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02327-7","article-title":"Gut microbiota changes in preeclampsia, abnormal placental growth and healthy pregnant women","volume":"21","author":"Huang L","year":"2021","unstructured":"Huang L, Cai M, Li L, et al.. Gut microbiota changes in preeclampsia, abnormal placental growth and healthy pregnant women. BMC Microbiol. 2021, 21:265. 10.1186\/s12866-021-02327-7","journal-title":"BMC Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2016.12.003","article-title":"Review: maternal health and the placental microbiome","volume":"54","author":"Pelzer E","year":"2017","unstructured":"Pelzer E, Gomez-Arango LF, Barrett HL, Nitert MD. Review: maternal health and the placental microbiome. Placenta. 2017, 54:30-7. 10.1016\/j.placenta.2016.12.003","journal-title":"Placenta"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113055","article-title":"Vascular dysfunction in preeclampsia","volume":"10","author":"Opichka MA","year":"2021","unstructured":"Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular dysfunction in preeclampsia. Cells. 2021, 10:3055. 10.3390\/cells10113055","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders HJ","year":"2020","unstructured":"Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020, 6:7. 10.1038\/s41572-019-0141-9","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24328","article-title":"Comparative risks of cardiovascular disease in patients with systemic lupus erythematosus, diabetes mellitus, and in general Medicaid recipients","volume":"72","author":"Barbhaiya M","year":"2020","unstructured":"Barbhaiya M, Feldman CH, Chen SK, Guan H, Fischer MA, Everett BM, Costenbader KH. Comparative risks of cardiovascular disease in patients with systemic lupus erythematosus, diabetes mellitus, and in general Medicaid recipients. Arthritis Care Res (Hoboken). 2020, 72:1431-9. 10.1002\/acr.24328","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening JJ","year":"2004","unstructured":"Weening JJ, D'Agati VD, Schwartz MM, et al.. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004, 65:521-30. 10.1111\/j.1523-1755.2004.00443.x","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie R","year":"2020","unstructured":"Furie R, Rovin BH, Houssiau F, et al.. Two-year, randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med. 2020, 383:1117-28. 10.1056\/NEJMoa2001180","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17049","article-title":"Review article: the future of microbiome-based therapeutics","volume":"56","author":"Gulliver EL","year":"2022","unstructured":"Gulliver EL, Young RB, Chonwerawong M, et al.. Review article: the future of microbiome-based therapeutics. Aliment Pharmacol Ther. 2022, 56:192-208. 10.1111\/apt.17049","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goab046","article-title":"Microbiome therapeutics: exploring the present scenario and challenges","volume":"10","author":"Yadav M","year":"2022","unstructured":"Yadav M, Chauhan NS. Microbiome therapeutics: exploring the present scenario and challenges. Gastroenterol Rep (Oxf). 2022, 10:goab046. 10.1093\/gastro\/goab046","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf271","article-title":"Bifidobacterium ameliorates lupus nephritis and modulates aberrant differentiation of lymphocyte subsets","volume":"64","author":"Wu L","year":"2025","unstructured":"Wu L, Guan Z, Zhang X, Liu Y, Chi S, Duan X, Su C. Bifidobacterium ameliorates lupus nephritis and modulates aberrant differentiation of lymphocyte subsets. Rheumatology (Oxford). 2025, 64:5518-28. 10.1093\/rheumatology\/keaf271","journal-title":"Rheumatology (Oxford)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.783679","article-title":"Understanding the gut-kidney axis in antineutrophil cytoplasmic antibody-associated vasculitis: an analysis of gut microbiota composition","volume":"13","author":"Yu M","year":"2022","unstructured":"Yu M, Li L, Ren Q, et al.. Understanding the gut-kidney axis in antineutrophil cytoplasmic antibody-associated vasculitis: an analysis of gut microbiota composition. Front Pharmacol. 2022, 13:783679. 10.3389\/fphar.2022.783679","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2285877","article-title":"Alterations of the gut microbiota in the lupus nephritis: a systematic review","volume":"45","author":"Wang A","year":"2023","unstructured":"Wang A, Zhao J, Qin Y, et al.. Alterations of the gut microbiota in the lupus nephritis: a systematic review. Ren Fail. 2023, 45:2285877. 10.1080\/0886022X.2023.2285877","journal-title":"Ren Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13020445","article-title":"The complex role of gut microbiota in systemic lupus erythematosus and lupus nephritis: from pathogenetic factor to therapeutic target","volume":"13","author":"Parodi E","year":"2025","unstructured":"Parodi E, Novi M, Bottino P, et al.. The complex role of gut microbiota in systemic lupus erythematosus and lupus nephritis: from pathogenetic factor to therapeutic target. Microorganisms. 2025, 13:445. 10.3390\/microorganisms13020445","journal-title":"Microorganisms"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-025-03995-5","article-title":"Uncovering potential biomarkers and metabolic pathways in systemic lupus erythematosus and lupus nephritis through integrated microbiome and metabolome analysis","volume":"25","author":"Cheng S","year":"2025","unstructured":"Cheng S, Chu X, Wang Z, Khan A, Tao Y, Shen H, Yang P. Uncovering potential biomarkers and metabolic pathways in systemic lupus erythematosus and lupus nephritis through integrated microbiome and metabolome analysis. BMC Microbiol. 2025, 25:275. 10.1186\/s12866-025-03995-5","journal-title":"BMC Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223929","article-title":"Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares","volume":"82","author":"Azzouz DF","year":"2023","unstructured":"Azzouz DF, Chen Z, Izmirly PM, et al.. Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares. Ann Rheum Dis. 2023, 82:1315-27. 10.1136\/ard-2023-223929","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa087","article-title":"The consequences of altered microbiota in immune-related chronic kidney disease","volume":"36","author":"Lau WL","year":"2021","unstructured":"Lau WL, Chang Y, Vaziri ND. The consequences of altered microbiota in immune-related chronic kidney disease. Nephrol Dial Transplant. 2021, 36:1791-8. 10.1093\/ndt\/gfaa087","journal-title":"Nephrol Dial Transplant"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.897971","article-title":"Sex-dependent Lupus Blautia (Ruminococcus) gnavus strain induction of zonulin-mediated intestinal permeability and autoimmunity","volume":"13","author":"Silverman GJ","year":"2022","unstructured":"Silverman GJ, Deng J, Azzouz DF. Sex-dependent Lupus Blautia (Ruminococcus) gnavus strain induction of zonulin-mediated intestinal permeability and autoimmunity. Front Immunol. 2022, 13:897971. 10.3389\/fimmu.2022.897971","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03413-7","article-title":"Outgrowth of Escherichia is susceptible to aggravation of systemic lupus erythematosus","volume":"26","author":"Gui L","year":"2024","unstructured":"Gui L, Zuo X, Feng J, et al.. Outgrowth of Escherichia is susceptible to aggravation of systemic lupus erythematosus. Arthritis Res Ther. 2024, 26:191. 10.1186\/s13075-024-03413-7","journal-title":"Arthritis Res Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094817","article-title":"Unravelling the link between the gut microbiome and autoimmune kidney diseases: a potential new therapeutic approach","volume":"25","author":"Tan DS","year":"2024","unstructured":"Tan DS, Akelew Y, Snelson M, Nguyen J, O'Sullivan KM. Unravelling the link between the gut microbiome and autoimmune kidney diseases: a potential new therapeutic approach. Int J Mol Sci. 2024, 25:4817. 10.3390\/ijms25094817","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2100082","article-title":"Phenotypic drift in lupus-prone MRL\/lpr mice: potential roles of microRNAs and gut microbiota","volume":"6","author":"Cabana-Puig X","year":"2022","unstructured":"Cabana-Puig X, Bond JM, Wang Z, et al.. Phenotypic drift in lupus-prone MRL\/lpr mice: potential roles of microRNAs and gut microbiota. Immunohorizons. 2022, 6:36-46. 10.4049\/immunohorizons.2100082","journal-title":"Immunohorizons"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409837","article-title":"Microbiota-derived inosine suppresses systemic autoimmunity via restriction of B cell differentiation and migration","volume":"12","author":"Gao L","year":"2025","unstructured":"Gao L, Zhang Y, Hu Z, et al.. Microbiota-derived inosine suppresses systemic autoimmunity via restriction of B cell differentiation and migration. Adv Sci (Weinh). 2025, 12:e2409837. 10.1002\/advs.202409837","journal-title":"Adv Sci (Weinh)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173421","article-title":"Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells","volume":"884","author":"Li D","year":"2020","unstructured":"Li D, Pan Y, Xia X, Liang J, Liu F, Dou H, Hou Y. Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells. Eur J Pharmacol. 2020, 884:173421. 10.1016\/j.ejphar.2020.173421","journal-title":"Eur J Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-025-00716-8","article-title":"Exploring the role of gut microbiota modulation in the long-term therapeutic benefits of early MSC transplantation in MRL\/lpr mice","volume":"30","author":"Pan Q","year":"2025","unstructured":"Pan Q, Guo F, Chen J, et al.. Exploring the role of gut microbiota modulation in the long-term therapeutic benefits of early MSC transplantation in MRL\/lpr mice. Cell Mol Biol Lett. 2025, 30:49. 10.1186\/s11658-025-00716-8","journal-title":"Cell Mol Biol Lett"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030653","article-title":"Involvement of gut microbiota in SLE and lupus nephritis","volume":"11","author":"Mohd R","year":"2023","unstructured":"Mohd R, Chin SF, Shaharir SS, Cham QS. Involvement of gut microbiota in SLE and lupus nephritis. Biomedicines. 2023, 11:653. 10.3390\/biomedicines11030653","journal-title":"Biomedicines"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.915179","article-title":"Gut microbiota in systemic lupus erythematosus and correlation with diet and clinical manifestations","volume":"9","author":"Wang X","year":"2022","unstructured":"Wang X, Shu Q, Song L, Liu Q, Qu X, Li M. Gut microbiota in systemic lupus erythematosus and correlation with diet and clinical manifestations. Front Med (Lausanne). 2022, 9:915179. 10.3389\/fmed.2022.915179","journal-title":"Front Med (Lausanne)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319101","article-title":"Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation","volume":"69","author":"Chen X","year":"2020","unstructured":"Chen X, Li P, Liu M, et al.. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut. 2020, 69:513-22. 10.1136\/gutjnl-2019-319101","journal-title":"Gut"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.320771","article-title":"Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts","volume":"131","author":"Jin J","year":"2022","unstructured":"Jin J, Gao L, Zou X, et al.. Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts. Circ Res. 2022, 131:492-506. 10.1161\/CIRCRESAHA.122.320771","journal-title":"Circ Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.167","article-title":"Intestinal flora and pregnancy complications: current insights and future prospects","volume":"3","author":"Tian Z","year":"2024","unstructured":"Tian Z, Zhang X, Yao G, et al.. Intestinal flora and pregnancy complications: current insights and future prospects. Imeta. 2024, 3:e167. 10.1002\/imt2.167","journal-title":"Imeta"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00469.2019","article-title":"Maternal microbiome and the hypertensive disorder of pregnancy, preeclampsia","volume":"318","author":"Beckers KF","year":"2020","unstructured":"Beckers KF, Sones JL. Maternal microbiome and the hypertensive disorder of pregnancy, preeclampsia. Am J Physiol Heart Circ Physiol. 2020, 318:H1-H10. 10.1152\/ajpheart.00469.2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14875","article-title":"Maternal microbiome in preeclampsia pathophysiology and implications on offspring health","volume":"9","author":"Ishimwe JA","year":"2021","unstructured":"Ishimwe JA. Maternal microbiome in preeclampsia pathophysiology and implications on offspring health. Physiol Rep. 2021, 9:e14875. 10.14814\/phy2.14875","journal-title":"Physiol Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58533-8","article-title":"Maternal gut microbiota influences immune activation at the maternal-fetal interface affecting pregnancy outcome","volume":"16","author":"Giugliano S","year":"2025","unstructured":"Giugliano S, Gatti A, Rusin M, et al.. Maternal gut microbiota influences immune activation at the maternal-fetal interface affecting pregnancy outcome. Nat Commun. 2025, 16:4326. 10.1038\/s41467-025-58533-8","journal-title":"Nat Commun"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00676-23","article-title":"Deep metagenomic characterization of the gut virome in pregnant women with preeclampsia","volume":"9","author":"Lv L-J","year":"2024","unstructured":"Lv L-J, Wen J-Y, Zhang Y, et al.. Deep metagenomic characterization of the gut virome in pregnant women with preeclampsia. mSphere. 2024, 9:e0067623. 10.1128\/msphere.00676-23","journal-title":"mSphere"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1469054","article-title":"Gut microbiota interacting with vitamin D but not anandamide might contribute to the pathogenesis of preeclampsia: a preliminary study","volume":"14","author":"Han XQ","year":"2024","unstructured":"Han XQ, Jiang HH, Chen ML, et al.. Gut microbiota interacting with vitamin D but not anandamide might contribute to the pathogenesis of preeclampsia: a preliminary study. Front Cell Infect Microbiol. 2024, 14:1469054. 10.3389\/fcimb.2024.1469054","journal-title":"Front Cell Infect Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75534-3","article-title":"Severe preeclampsia is associated with a higher relative abundance of Prevotella bivia in the vaginal microbiota","volume":"10","author":"Lin CY","year":"2020","unstructured":"Lin CY, Lin CY, Yeh YM, et al.. Severe preeclampsia is associated with a higher relative abundance of Prevotella bivia in the vaginal microbiota. Sci Rep. 2020, 10:18249. 10.1038\/s41598-020-75534-3","journal-title":"Sci Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15844","article-title":"The gut microbiota composition and metabolites are different in women with hypertensive disorders of pregnancy and normotension: a pilot study","volume":"50","author":"Wu Z","year":"2024","unstructured":"Wu Z, Ge M, Liu J, Chen X, Cai Z, Huang H. The gut microbiota composition and metabolites are different in women with hypertensive disorders of pregnancy and normotension: a pilot study. J Obstet Gynaecol Res. 2024, 50:334-41. 10.1111\/jog.15844","journal-title":"J Obstet Gynaecol Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1042\/CS20191253","article-title":"Short-chain fatty acids accompanying changes in the gut microbiome contribute to the development of hypertension in patients with preeclampsia","volume":"134","author":"Chang Y","year":"2020","unstructured":"Chang Y, Chen Y, Zhou Q, Wang C, Chen L, Di W, Zhang Y. Short-chain fatty acids accompanying changes in the gut microbiome contribute to the development of hypertension in patients with preeclampsia. Clin Sci (Lond). 2020, 134:289-302. 10.1042\/CS20191253","journal-title":"Clin Sci (Lond)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01548-14","article-title":"Intestinal dysbiosis associated with systemic lupus erythematosus","volume":"5","author":"Hevia A","year":"2014","unstructured":"Hevia A, Milani C, L\u00f3pez P, et al.. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014, 5:e01548-14. 10.1128\/mBio.01548-14","journal-title":"mBio"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/srep24072","article-title":"Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients","volume":"6","author":"L\u00f3pez P","year":"2016","unstructured":"L\u00f3pez P, de Paz B, Rodr\u00edguez-Carrio J, Hevia A, S\u00e1nchez B, Margolles A, Su\u00e1rez A. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep. 2016, 6:24072. 10.1038\/srep24072","journal-title":"Sci Rep"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1202850","article-title":"Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus","volume":"14","author":"Yao K","year":"2023","unstructured":"Yao K, Xie Y, Wang J, Lin Y, Chen X, Zhou T. Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus. Front Immunol. 2023, 14:1202850. 10.3389\/fimmu.2023.1202850","journal-title":"Front Immunol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1497756","article-title":"Gut dysbiosis is associated with difficult-to-treat rheumatoid arthritis","volume":"11","author":"Ruiz-Lim\u00f3n P","year":"2024","unstructured":"Ruiz-Lim\u00f3n P, Mena-V\u00e1zquez N, Moreno-Indias I, et al.. Gut dysbiosis is associated with difficult-to-treat rheumatoid arthritis. Front Med (Lausanne). 2024, 11:1497756. 10.3389\/fmed.2024.1497756","journal-title":"Front Med (Lausanne)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuae057","article-title":"Short-chain fatty acids and preeclampsia: a scoping review","volume":"83","author":"Zhao HJ","year":"2025","unstructured":"Zhao HJ, Chen Y, Liu T, McArthur K, Mueller NT. Short-chain fatty acids and preeclampsia: a scoping review. Nutr Rev. 2025, 83:e683-93. 10.1093\/nutrit\/nuae057","journal-title":"Nutr Rev"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.321701","article-title":"Dysbiosis in preeclampsia and treatment with short chain fatty acids","volume":"131","author":"Mackay CR","year":"2022","unstructured":"Mackay CR, Marques FZ. Dysbiosis in preeclampsia and treatment with short chain fatty acids. Circ Res. 2022, 131:507-9. 10.1161\/CIRCRESAHA.122.321701","journal-title":"Circ Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.878924","article-title":"The diagnostic potential of gut microbiota-derived short-chain fatty acids in preeclampsia","volume":"10","author":"Li J","year":"2022","unstructured":"Li J, Wang L, Chen H, et al.. The diagnostic potential of gut microbiota-derived short-chain fatty acids in preeclampsia. Front Pediatr. 2022, 10:878924. 10.3389\/fped.2022.878924","journal-title":"Front Pediatr"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9351507","article-title":"Proteobacteria: a common factor in human diseases","volume":"2017","author":"Rizzatti G","year":"2017","unstructured":"Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: a common factor in human diseases. Biomed Res Int. 2017, 2017:9351507. 10.1155\/2017\/9351507","journal-title":"Biomed Res Int"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214856","article-title":"Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal","volume":"78","author":"Azzouz D","year":"2019","unstructured":"Azzouz D, Omarbekova A, Heguy A, et al.. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019, 78:947-56. 10.1136\/annrheumdis-2018-214856","journal-title":"Ann Rheum Dis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/BF02686087","article-title":"Molecular mimicry and auto-immunity","volume":"32","author":"Blank M","year":"2007","unstructured":"Blank M, Barzilai O, Shoenfeld Y. Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol. 2007, 32:111-8. 10.1007\/BF02686087","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041165","article-title":"Lupus nephritis and dysbiosis","volume":"11","author":"Monticolo M","year":"2023","unstructured":"Monticolo M, Mucha K, Foroncewicz B. Lupus nephritis and dysbiosis. Biomedicines. 2023, 11:1165. 10.3390\/biomedicines11041165","journal-title":"Biomedicines"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1364333","article-title":"Urinary microbiome profiling as a non-invasive tool for identifying biomarkers in systemic lupus erythematosus and lupus nephritis","volume":"14","author":"Shi B","year":"2024","unstructured":"Shi B, Chen F, Gong J, Khan A, Qian X, Xu Z, Yang P. Urinary microbiome profiling as a non-invasive tool for identifying biomarkers in systemic lupus erythematosus and lupus nephritis. Front Cell Infect Microbiol. 2024, 14:1364333. 10.3389\/fcimb.2024.1364333","journal-title":"Front Cell Infect Microbiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202010_23235","article-title":"Changes in intestinal flora in preeclampsia rats and effects of probiotics on their inflammation and blood pressure","volume":"24","author":"Sun BM","year":"2020","unstructured":"Sun BM, Meng L, Liu H, Bao D. Changes in intestinal flora in preeclampsia rats and effects of probiotics on their inflammation and blood pressure. Eur Rev Med Pharmacol Sci. 2020, 24:10155-61. 10.26355\/eurrev_202010_23235","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1295378","article-title":"Synbiotic regulates gut microbiota in patients with lupus nephritis: an analysis using metagenomic and metabolome sequencing","volume":"15","author":"Zhu Q","year":"2024","unstructured":"Zhu Q, Cui J, Liu S, Wei S, Wu Q, You Y. Synbiotic regulates gut microbiota in patients with lupus nephritis: an analysis using metagenomic and metabolome sequencing. Front Microbiol. 2024, 15:1295378. 10.3389\/fmicb.2024.1295378","journal-title":"Front Microbiol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00004.2023","article-title":"Vitamin D regulates microflora and ameliorates LPS-induced placental inflammation in rats","volume":"55","author":"Ma Y","year":"2023","unstructured":"Ma Y, Zhang Y, He Q, Xu T, Huang W, Deng X, Qian Y. Vitamin D regulates microflora and ameliorates LPS-induced placental inflammation in rats. Physiol Genomics. 2023, 55:286-96. 10.1152\/physiolgenomics.00004.2023","journal-title":"Physiol Genomics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443421-microbiome-differences-in-preeclampsia-versus-lupus-nephritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T20:26:46Z","timestamp":1768163206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443421-microbiome-differences-in-preeclampsia-versus-lupus-nephritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.101296","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,11]]}}}